Goldman Sachs chief U.S. equity strategist David Kostin is bullish. He expects the S&P 500 to rally to 1,750 by the end of the year.
However, this is not to say that every stock in the market is a good buy right now.
In his new US Monthly Chartbook, Kostin offers a list of the 40 stocks with the most downside relative to Goldman analysts' price targets.
We pulled the 10 stocks that have at least 20% to lose.
10. Boston Scientific: 20.2% Downside
Ticker: BSX
Sector: Healthcare
Recent Price: $9.27
Downside: 20.2%
Like other medical device companies, Boston Scientific is now subject to a 2.3% device tax that came as part of the Affordable Care Act.
Source: Goldman Sachs
9. Seagate Technology: 21.9% Downside
Ticker: STX
Sector: Technology
Recent Price: $44.83
Downside: 21.9% (rating: neutral)
Seagate, a hard-disk drive producer, has seen its revenues drop by 17%, 2%, and 4% in the last three quarters, respectively.
Source: Goldman Sachs
8. Juniper Networks: 22.3% Downside
Ticker: JNPR
Sector: Technology
Recent Price: $19.31
Downside: 22.3%
Last month, shares of the networking equipment company jumped upon comments from their CEO Kevin Johnson that demand from its telecom customers was looking good.
Source: Goldman Sachs
See the rest of the story at Business Insider